Charcoal adsorption of unbound acyclovir rather than ammonium sulfate precipitation of bound acyclovir to facilitate the separation of bound antigen from free antigen gave rise to a radioimmunoassay which was quicker yet still as sensitive and accurate as that previously used.
Acyclovir, 9-(2-hydroxyethoxymethyl) guanine (ACV), is a potent and selective antiviral agent with activity against herpes Simplex virus type 1 and type 2 (1, 4) , and it has recently been clinically tested. Quinn et al. (3) described the development of a sensitive radioimmunoassay (RIA) for ACV which uses ammonium sulfate precipitation to separate bound drug from free drug; this assay has recently been employed in field studies (2) . We now describe a modification of this RIA which uses dextran-coated charcoal to separate bound ACV from free ACV. This modification has resulted in a faster assay which is as accurate and reproducible as the previously described RIA Appropriately diluted antiserum (100 ,ul) in RIA buffer was then added, and the solution was blended in a Vortex mixer for 2 s. After incubation of the reaction mixture for various lengths of time at the temperatures indicated, the mixture was cooled to 4°C, and 200 ,ul of ice-cold charcoal suspension (taken from a rapidly stirred suspension with a spring-loaded repeating syringe) was added rapidly. The solution was blended in a Vortex mixer for 2 s and centrifuged at 2,400 x g for 15 min at 4°C. Supematant (500 ,ul) was noixed with 5 ml of Aquasol 2 (New England Nuclear Corp., Boston, Mass.) and counted at an efficiency of 34%.
Various concentrations of dextran and charcoal were studied (data not shown). The concentrations of charcoal and dextran used in this assay were chosen so that background counts per minute in the absence of antiserum were less than 3.5% of the counts contributed by the added [3H]succinyl-ACV and so that'the concentration of [3H]succinyl-ACV bound by antibody in the 'absence of unlabeled ACV was similar to that obtained in the ammonium sulfate RIA. We also examined the effect of the length of incubation of the sample with charcoal before centrifugation and found little variability in the results over a range of 0 to 20 min.
When the ammonium sulfate RIA was used, the incubation of antiserum with labeled and unlabeled ligands was carried out as described above for the charcoal RIA, but the separation of bound ligand' from free ligand was done with ammonium sulfate precipitation as previously described (3) .
All data obtained from liquid scintillation by plotting BIBo on log-logit paper. ACV concentrations were read directly from the graph or obtained from statistical analysis of the data by linear regression analysis. When the antiserum and ligand were incubated overnight at 4°C before separation of bound hapten from free hapten, the standard curves generated by the two assays were in excellent agreement (Fig. 1) .
Quinn et al. reported for the ammonium sulfate assay that a 2-h incubation was not quite as effective as an overnight incubation at 4°C (3). In the present study, incubation at room temperature for 90 min, followed by incubation at 4°C for 90 min before separation of bound hapten from free hapten gave results nearly identical to those obtained with overnight incubation at 4°C (data not shown), and we have adopted this 3-h incubation for use with the charcoal assay.
To assess the precision of the assay, we carried out a separate experiment in which each point on the standard curve (ranging from 1 to 500 pmol per tube) was derived from 10 replicate samples. For the curve so generated, the standard deviation from the mean of BIBO ranged from 4.7 to 1.8% (mean, 3.2%) for the charcoal method and 10.9 to 1.8% (mean, 5.0%) for the ammonium sulfate method.
When either known concentrations of ACV prepared by serial dilutions of a 200 ,uM standard solution (data not shown) or plasma samples from patients receiving ACV (Fig. 2) were run in the two assays simultaneously, both assays yielded values in excellent agreement.
The specificity of rabbit antiserum no. 110 in this modification of the RIA was similar to that described for antisera used previously (3) .
Of major significance is the fact that the time required to process 60 sample tubes after incubation with antibody and antigen was of plasma ACV concentrations. The rapidity of this assay more conveniently allows ACV levels in samples taken from patients to be determined on the same day that the samples are obtained, thus providing more timely data to aid in making therapeutic decisions which might alter a patient's clinical course. 
